Navigation Links
Resveratrol prolongs lifespan and delays onset of aging-related traits in a short-lived vertebrate

By studying a particularly short-lived fish species, researchers have been able to show that a natural compound previously shown to extend lifespan in non-vertebrate organisms can also do so in at least one vertebrate species. The findings, reported by Alessandro Cellerino of the Scuola Normale Superiore, Pisa, and colleagues, support the potential utility of the compound in human aging research.

The development of drugs able to retard the onset of aging-related diseases and improve quality of life in the elderly is a growing focus of aging research and public health in modern society. But the successful development of drugs aimed at aging-related diseases needs to face the challenge posed by the lifespan of the available animal models--mammalian models for aging are relatively long-lived and aren't as easily studied as shorter-lived species.

Resveratrol is an organic compound naturally present in grapes--and particularly enriched in red wine--and was previously shown to prolong lifespan in non-vertebrate model organisms such as yeast, the worm C. elegans, and the fruit fly Drosophila. However, until now, life-long pharmacological trials were performed in the worm or fly model organisms because of their very small size, very short natural lifespan, and affordable cultivation costs. Laboratory mice, on the other hand, live more than two years and are relatively expensive to maintain, making large-scale, life-long pharmacological trials in mice unaffordable.

Recently, a small fish species with a captive lifespan of only three months was described by Cellerino and colleagues. In the new work, the researchers used this short-lived fish to test the effects of resveratrol on aging-related physiological decay. The researchers added resveratrol to daily fish food and found that this treatment increased longevity and also retarded the onset of aging-related decays in memory and muscular performance.

Resveratrol appears to be the first molecul
'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. Researchers extend mouse lifespan by protecting against free radicals
2. New lifespan extension genes found
3. MicroRNA gene that regulates lifespan found by Yale scientists
4. Fish evolve a longer lifespan by evolving a longer reproductive period, researchers find
5. New research says winning a Nobel Prize adds nearly 2 years to your lifespan
6. Researchers find link between food odors and lifespan in fruit flies
7. Sexual reproduction delays aging in a mammalian species
8. Matrilin-3 gene discovered to prevent onset of osteoarthritis
9. Gene therapy prevents the onset of diabetic symptoms in mice
10. Temperament linked to onset of cancer and early death in female rats
11. Canadian study shows bilingualism has protective effect in delaying onset of dementia by four years
Post Your Comments:
(Date:1/22/2015)... the leading source of biometrics industry news, interviews and thought ... "When we launched FindBiometrics 12 years ago the industry ... and CEO of FindBiometrics. "Now it,s maturing very quickly. More ... on a very broad scale.  We are known for providing ...
(Date:1/22/2015)... MADISON, Wis. , Jan. 15, 2015  BellBrook ... for drug discovery, announced the launch of a ... of the company,s Transcreener UDP Assay, a high ... enzymes. The new assay will allow for sensitive ...
(Date:1/22/2015)... and POINT ROBERTS, Washington , January 20, ... leading sectors including technology and tech stocks, releases video from ... master pickpocket and security consultant Apollo Robbins . ... talks about the Wocket™ biometric smart wallet, a product of ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
... Cell-based therapies have been shown to enhance ... produced only "modest results." In an effort to ... team from Germany has taken epithelial cells from ... them into mesenchymal cells. After transplanting the transitioned ...
... better at repelling attacks by mountain pine beetles, which have ... by the University of Colorado Boulder. The findings, published ... land managers make decisions about which trees to cull and ... against pine beetle infestation. The current mountain pine beetle ...
... the important transducers of noxious stimuli in the primary ... and hyperalgesia. However, there is no direct evidence that ... neuropeptide release from primary afferent neurons. A recent study ... Medicine in Japan demonstrated for the first time that ...
Cached Biology News:Transitioning epithelial cells to mesenchymal cells enhances cardiac protectivity 2Slippery bark protects trees from pine beetle attack, according to CU-Boulder study 2
(Date:3/3/2015)... 2015 Becht Engineering Co., Inc., ... has acquired The CECON Group, Inc., located in ... not announced. , Becht Engineering (http://www.becht.com ) ... including oil and gas production, refining, petrochemical, chemical, ... power sectors. The company has twelve offices in ...
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research ... announced the addition of Jain PharmaBiotech,s new report ... to their offering. , ... is to match the right drug to the ... design the appropriate treatment for a patient according ...
(Date:3/3/2015)... 2015  Johnson & Johnson Innovation LLC today announced ... (JLABS @SSF), a 30,000-square foot incubator located ... Francisco, Calif. The Johnson & Johnson Innovation, ... from across the healthcare spectrum including biotech, pharmaceutical, medical ... first resident startups have been selected, including the winners ...
(Date:3/3/2015)... ROCKVILLE, Md. , March 3, 2015  Synthetic Biologics, ... serious infections and diseases, with a focus on protecting the ... Officer, is scheduled to present at the 27th Annual ROTH ... Laguna Niguel in Dana ... on Tuesday, March 10, 2015 at 1:00 p.m. (Pacific Time). ...
Breaking Biology Technology:Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 2Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 4Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 5Synthetic Biologics to Present at the 27th Annual ROTH Conference 2
... Valeant,Pharmaceuticals International (NYSE: VRX ) ... to acquire Dow Pharmaceutical Sciences, Inc., a privately,held ... topical,products on a proprietary basis, as well as ... enhances Valeant,s,dermatology franchise in the United States through ...
... Resource enable researchers to quickly and effectively use this invaluable resource. ... ... OpenHelix today announced the availability of a new tutorial ... a public resource for the analysis of prokaryotes, including the complete ...
... Dec. 9 ev3 Inc. (Nasdaq: ... that it has received,510(k) clearance from the U.S. ... 0.035" and NanoCross 0.014" peripheral angioplasty balloon,catheters. ... EverCross and,NanoCross peripheral balloon catheters globally in January ...
Cached Biology Technology:Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million 2Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million 3Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million 4Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million 5New Online Tutorial for the Comprehensive Microbial Resource (CMR) 2ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons 2ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons 3